Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Icu Medical (ICUI) Land & Improvements (2023 - 2025)

Icu Medical's Land & Improvements history spans 3 years, with the latest figure at $179.9 million for Q3 2025.

  • For the quarter ending Q3 2025, Land & Improvements fell 39.07% year-over-year to $179.9 million, compared with a TTM value of $179.9 million through Sep 2025, down 39.07%, and an annual FY2024 reading of $177.1 million, down 36.36% over the prior year.
  • Land & Improvements for Q3 2025 was $179.9 million at Icu Medical, up from $179.0 million in the prior quarter.
  • The five-year high for Land & Improvements was $295.3 million in Q3 2024, with the low at $174.1 million in Q1 2025.
  • Average Land & Improvements over 3 years is $231.7 million, with a median of $229.1 million recorded in 2023.
  • Year-over-year, Land & Improvements plummeted 36.36% in 2024 and then tumbled 39.07% in 2025.
  • Tracing ICUI's Land & Improvements over 3 years: stood at $278.3 million in 2023, then plummeted by 36.36% to $177.1 million in 2024, then increased by 1.58% to $179.9 million in 2025.
  • Per Business Quant, the three most recent readings for ICUI's Land & Improvements are $179.9 million (Q3 2025), $179.0 million (Q2 2025), and $174.1 million (Q1 2025).